Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug DiscoveryArup K. Ghose, John P. Mallamo, Torsten Herbertz et al.|ACS Chemical Neuroscience|2011Cited by 436
CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.Bruce Ruggeri, Craig A. Dionne, Diane E. Gingrich et al.|PubMed|2003Cited by 124
Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a DerivativesMasami Kaneko, Chikara Murakata, Yutaka Saito et al.|Journal of Medicinal Chemistry|1997Cited by 120
Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitorsThelma S. Angeles, Robert L. Hudkins|Expert Opinion on Drug Discovery|2016Cited by 113
The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicitySheila Miknyoczki, Bruce Ruggeri, Hong Chang et al.|Molecular Cancer Therapeutics|2007Cited by 112